Parabilis Medicines Inc. (PBLS) on Thursday reported a loss of $52.5 million in its second quarter. The Cambridge, Massachusetts-based company said it had a loss of $2.32 per share. Losses, adjusted for non-recurring costs, were $2.13 per share. The clinical stage pharmaceutical company posted revenue of $148,000 in the period.
Original reporting: Alexandria, VA News – WTOP News — read the source article.